Disaar Arbutin & Glutathione series can support both directions
Small sample sizes, short durations, and inconsistent outcome measures limit definitive conclusions
How TrufaMED prescribes GHK-Cu In the TrufaMED performance medicine program, GHK-Cu is prescribed as injectable subcutaneous peptide therapy, typically in 12-week initial protocols with reassessment at 90 days
However, they reported notable improvements in clinician-rated assessments, with patients ages 315 years of age showing significant improvement in the sulforaphane treatment group on the OSU Autism rating scale DSM-IV (OARS-4) in particular (Ou et al., 2024)
Beyond passive data analysis, future AI tools will be embedded into closed-loop systems capable of real-time interpretation and actuation, adjusting drug release or material properties based on dynamic physiological feedback